CathRx sells first product to Europe
Wednesday, 17 September, 2008
CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.
Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.
The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.
CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.
Ancient lead exposure shaped human evolution
An international study claims that exposure to lead may have influenced the evolution of hominid...
Reproductive impacts of PFAS exposure revealed
New studies have found that PFAS exposure can significantly alter male reproductive health, and...
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
